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Summary
Of all the biochemically defined mouse MHC class I molecules, the Qa-1 antigens are the only
ones for which a gene has not been identified. Recent evidence has suggested that Qa-1 antigens
are functional class I molecules and can function as restriction elements for y1b T cells. We
have examined the relationship between Qa-1 and the product of gene 37, a presumed novel
class I antigen encoded within the TL region. Immunoprecipitation and polyacrylamide gel
electrophoresis analysis of the molecules reactive with anti-Qa-1 and anti-37 sera show that the
Qa-1 molecule of Qa-1b (Qa-1.2) mouse strains is identical to the product of gene 37 on the
basis of molecular weight, pI, and strain distribution. Immunodepletion, biosynthetic labeling,
and tunicamycin treatment confirm that the protein encoded by gene 37 in Qa-1b mice is Qa-1.2.
In contrast, the anti-37 serum was unable to recognize the Qa-1 molecule in Qa-1' strains. Given
the fact that the only allele to gene 37 thus far identified in a Qa-la strain (A/J) has a termination
codon in the 0 domain, our data lead us to conclude that the Qa-1 molecule expressed in Qa-1'
mice is not a true allelic product of the gene 37 encoded antigen of Qa-Ib mouse strains.
T
he Qa-1 alloantigens are class I glycoproteins encoded
by loci telomeric to H-2 in the TL region of the MHC
(reviewed in references 1-3). The Qa-1 antigenic system was
first identifiedby Stanton and Boyse (4), who observed a novel
reactivity in anti-TL serum for peripheral lymphocytes that
was distinct from TL on the basis oftissue distribution. This
newly identified antigen was designated Qa-1 and was as-
signed to the TL region (1, 4). Later, several laboratories in-
dependently demonstrated that Qa-1 could be detected by
alloreactive CTL in an H-2 nonrestricted manner suggesting
that Qa-1 had functions similar to classical H-2K,D anti-
gens (5-8). Subsequent biochemical studies revealed Qa-1 an-
tigens to have structural properties characteristic of class I
antigens, i.e., cell surface glycoproteins with molecular weight
of -48,000 and associated with 02-microglobulin (9-11).
Four alleles (a,b,c,d) have been defined for the Qa-1 locus
by CTL reactions (12-15). The protein product in the Qa-1'
strains is denoted as Qa-1.1, and that in Qa-11 1 strains as
Qa-1.2. The Qa-1 molecules from Qa-1c and Qa-ld strains are
very similar to Qa-1.2 as shown by serological, biochemical,
and CTL analyses (12-16).
Original reports using serological techniques characterized
the expression Qa-1 as limited to cells ofhematopoietic origin,
similar to other antigens encoded by the QTL region genes
(1-3). Recent investigations using more sensitive monoclonal
anti-Qa-1 CTL have revealed Qa-1 to be widely expressed,
resembling the ubiquitously expressed H-2K,D,L antigens
(17) . Although the Qa-1 alloantigens can serve as targets of
H-2 nonrestricted cell-mediated killing analogous to H-2K
and D molecules, it was not until recently that "classical"
class I molecule functions were reported for Qa-1. Vidovic
et al. (18) demonstrated using antiserum blocking that Qa-1
can function in presentation of conventional antigen [co-
polymer (GluTyr)] to a y/b T cell hybridoma. In addition,
there are at least two otherdescribed y/b T cell hybridomas
that recognize or are restricted to class I molecules encoded
in the TL region (19, 20). Also, Aldrich et al. (17) have de-
scribed a locus, Qdm, linked to the H-2D region that is re-
quired for the expression ofcertain CTLdefined Qa-1 deter-
minants. A possible interpretation from these data is that Qa-1
may restrict the recognition of a self protein or peptide, the
product of Qdm. Thus, Qa-1 and other TL region products
may have a physiological role in presenting antigen to y/b
ora/0 T cells; the low level of polymorphism would be con-
sistent with these molecules having a more limited and special-
ized role than classical class I antigens. Further support for
possible class I-like functions of these molecules stems from
computer aided models comparing the structure predicted
from Q and TL gene sequences with the published structure
of the HLA-A2 molecule (21-23). These molecules have
sufficient homology to conventional class I antigens overall
and in key regions of the molecule to predict that they have
class I-like structure with a potential peptide binding site.
Of the 23-28 class I genes identified within the Q/TL
region of the mouse MHC, none have been shown to encode
Qa-1 to date. This has hindered further investigations into
the possible role of Qa-1 as a restriction element, as well as
any other functional properties it might possess. Previously,
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while investigating the diversity of H-2-related transcripts
in DBA/2 (H-2Dd) liver. Gene 37 was subsequently shown
to be located in the TL region and closely related to the
T10° gene (25).1 Analyses of gene 37 by RFLP and
Northern blots have shown it to have a low degree of poly-
morphism andto be ubiquitously expressed (24, 25). Cochet
et al. (27) have demonstrated in Lcells transfected with gene
37 and in spleen cellsthat antisera against novelgene 37 pep-
tide sequences specifically precipitate the37 product expressed
on the cell surface. The striking similarities between gene
37 andQa-1, namely their shared ubiquitous tissue distribu-
tion and low polymorphism, have led us to investigate the
possibility that Qa-1 is encoded by gene 37. To do so, we
have used antisera specific for Qa-1.1, Qa-1.2, and a peptide
predicted from the gene 37 sequence to immunoprecipitate
proteins recognized by each from Qa-1a and Qa-Ib mouse
strains. Ourresults indicate that the Qa-1.2 antigenfrom Qa-
1b strains is encoded by gene 37.
Materials and Methods
Mice.
￿
B6Tlaa and ATlab mouse strains were bred in our
mousecolony at Baylor College of Medicine. C57BL/6J (B6)2 and
all other mice were purchased from theJackson Laboratory Bar
Harbor, ME.
Serological Reagents.
￿
Antisera to products of the Qa-1a (anti-
Qa-1.1) and Qa-1b (anti-Qa-1.2) alleles were prepared as previously
described (16). The anti-37 peptide serum(207-1) directed against
thecytoplasmic tail of thegene 37 product (amino acids 326-337)
has been previously described (27), and was a gift from John E.
Coligan (National Institutes of Health, Bethesda, MD). Anti-H-
2K6 [(A x B10.A)F1 anti-B10.A(5R)] was obtained from theRe-
search ResourcesBranch, NIH. Normal mouseserum (NMS) and
normal rabbit serum (NRS) were purchased form Pd-Freez Bio-
logicals, Rogers, AR.Theanti-Qa-1.1,Qa-1.2, and NMSreagents
used forimmunoprecipitations were IgGfractions isolated on Affi-
gel protein A (Bio-Rad Laboratories, Richmond, CA).
Cell Culturing and Radiolabeling of Cells.
￿
Con A-activated T
cell blasts (CAB) were prepared as described (28). For internal
labeling, 50 x 106cells were incubated for 30 min in 1 ml HBSS
plus 10% FCS containing 1.25 MCi of [
3sS]methionine (Amer-
sham Corp., ArlingtonHeights, IL). At theendthelabeling period,
cold methionine containing medium (supplemented Mishell-Dutton
medium, sMDM) was added to stop the labeling reaction. Cells
were then either washed threetimes with Dulbeccos PBS (D-PBS)
and immediately lysed with 0.5% NP40 in D-PBS, or recultured
at 37°C in sMDM at 2 x 106/ml and chased for varying lengths
of time. After each chase, cells were washed and lysed as above.
For cell surface iodination, 50 x 106 cells were labeled in D-PBS
with 2.5 mCi'211 (Amersham Corp.) by the lactoperoxidase cata-
lyzed procedure (10). At the end of the labeling period, the cells
were washed andlysed as above. Allcellswere lysedin thepresence
of 1 mM PMSF and33 Itg/ml ofaprotinin (Boehringer Mannheim
1 Although located 3' and linked to BALB/c gene T10c,gene 37 has not
as yetbeen givena Tgene number; T1& has been assigned to a different
gene that has not been linked to other TL genes (26).
2 Abbreviations used in this paper. B6, C57BL/6J; CAB, Con A-activated
T cell blasts; NMS, normal mouse serum; NRS, normal rabbit serum;
D-PBS, Dulbeccosphosphate-buffered saline; 1-D, onedimensional; 2-D,
two dimensional.
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Biochemicals, Indianapolis, IN)to inhibit endogenous protease ac-
tivity. To examine the contribution of N-linked carbohydrates to
the cell surface expression of Qa-1 and 37, CAB were incubated
in sMDM containing 0.5 wg/ml tunicamycin (Calbiochem-Behring
Corp., La Jolla, CA) for 12 h at 37°C. The tunicamycin-treated
blasts were iodinatedandimmunoprecipitated as above. For internal
labeling, CAB were preincubated in sMDM-containing 10 Wg/ml
tunicamycin for30minat 37°C. At theendoftheincubation period,
cells were washed in methionine-free medium and labeled in the
presence of tunicamycin (10 wg/ml) with [15S]methionine andim-
munoprecipitated as above.
Immunoprecipitation, SDS-PAGE, and Toro-Dimensional (2-D) Gel
Analysis. Cell lysateswere depleted of Ig and "nonspecific" mate-
rial by preclearing with BSAsepharose, goat anti-mouse Ig-Sepha-
rose, andprotein A-agarose (Pierce Chemical Co., Rockford, IL).
Aliquots of the lysates (-12 x 106 cell equivalents) were in-
cubated with specific or control antibodies at 4°C overnight. The
immune complexeswere recoveredon protein A-agaroseandwashed
four timeswith PBScontaining 0.5% NP40, 0.25% sodium deox-
ycholate, 0.1% SDS, and twice with H20. For 1-D gels, immuno-
precipitates were eluted from protein A-agarose with solubilizing
buffer and analyzed by SDS-PAGE on 12.5% gels under reducing
conditions as described by Laemmli (29). For 2-D gels, immuno-
precipitates were eluted from protein A-agarose in isoelectric
focusing (IEF) solubilizing buffer and analyzed on a pH 5-7 IEF
gel followed by SDS-PAGE on a 12.5% gel (16). BSA (68,000),
ovalbumin(45,000),chymotrypsinogen (24,000), andcytochrome
C (12,500) were used as molecularweight markers. Gels were dried
and analyzed by fluorography or autoradiography.
N-Glycanase Treatment.
￿
Immunoprecipitates were eluted with
1 ml of SDS solubilizing buffer, dialyzed overnight against H20,
lyophilized, and resolubilized in 0.2 M sodium phosphate pH 8.6
and 1% NP40. Each sample was digested with a total of 2 U of
N-glycanase (Genzyme Corp., Boston, MA) (1 Uadditionsat 0 and
2 h), and the reaction was stopped at 4 h. Sampleswere then dia-
lyzed against H2O overnight, lyophilized, and analyzed by 1-D
and 2-D PAGE.
Results
TheMolecules Reactive with the Qa-l-speck and 37 Peptide
Antisera AreBiochemically Similar. To address the relation-
ship between the Qa-1.1 and Qa-1.2 antigens and the gene
37 product, we first examined the reactivity of the anti-37
andanti-Qa-1 sera with the TL region congenic mousestrains,
B6 (Qa-1b) and B6.Tlaa (Qa-1a). The anti-37 serum was
raised in rabbits against a peptide corresponding to residues
326-337in the cytoplasmic region deducedfrom the 37 gene
sequence (27). Cochet et al. (27) reported that this antiserum
precipitated a -45.5-kD polypeptide associated with (32-micro-
globulin from the cell surface of splenocytes of H-2b,d, and k
(B6, BALB/c, and CBA) mice, and that this product of gene
37 was not found on the cell surface of splenorytes from
H-2a and , (A/J and SJL/J) mice. It intriguedus that the three
strains that were reactive with the anti-37 serum were Qa-Ib,
while the two negative strains were Qa-la.
To investigate possible biochemical similarities betweenthe
Qa-1 molecules and the 37 product, lysates of 1251 surface-
labeled T cell blasts from B6 and B6Tlaa were immunopre-
cipitated with the described antisera and analyzed via 1-D
SDS-PAGE. Con A-activated T cells were used instead ofsplenocytes due to increased Qa-1 expression on the cell sur-
face (16) . The anti-Qa-1.1 and anti-Qa-1.2 sera have specificity
for Qa-1 molecules encoded by Qa-1 a and Qa-1b strains,
respectively (16) . As depicted in Fig. 1 A, both the anti-
Qa-1.1 and Qa-1.2 sera immunoprecipitated a -48-kD pro-
tein associated with 02-microglobulin (-12 kD) from the
appropriate mouse strain . Anti-Qa-1.1. has been shown to
react with the -46-kD TL antigen present on activated T
cells (30) and can not be distinguished from Qa-1.1 on the
1-D gel . Anti-37 also reacted with a protein in B6 of similar
M (-48,000) as well as an additional slightly higher spe-
cies of -50,000 . However, anti-37 only weakly precipitated
Figure 1 .
￿
Comparative 1-D and 2-D gel analysis ofQa-1 .2, Qa-1 .1, and
the product of gene 37 from activated B6 (Qa-Ib) and B6Tlaa (Qa-la) T
cells . Iodinated B6 and B631v T cell blasts were immunoprecipitated with
anti-Qa-1 .1, anti-Qa-1 .2, anti-37, andNRS and then analyzed by 1-D (A)
and 2-D (B) gel electrophoresis . The band at -12,000 mol wt represents
S2-microglobulin . Equal areas from each autoradiogram are shown in B ;
the basic end of the IEF first dimension gel is to the left .
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a protein product from B6Tlaa in the 48-50,000 mol wt
range . Similarities between Qa-1 and 37 were further exam-
ined by 2-D gels. As shown in Fig. 1 B, the anti-Qa-1.2 and
anti-37 reactive proteins have identical isoelectrophoretic pat-
terns. A species of similar charge heterogeneity but slightly
higher molecular weight was detected with the anti-37 serum,
consistent with the above SDS-PAGE analysis. 2-D analysis
of anti-Qa-1.1 precipitates from B6.Tlaa revealed two pro-
teins, Qa-1.1 and TL ; the latter has a slightly lower molec-
ular weight and is depicted with an arrow. As can be seen,
neither Qa-1.1 norTL were present in the anti-37 precipitates.
The identity of the molecule from B6.ITlaa seen on the
1-D gels that is weakly precipitated by anti-37 remains un-
clear, but may represent weak cross-reactivity with H-2Kb .
The gene 37-derived peptide used to generate the antiserum
shows littlehomology with other class I cytoplasmic regions.
However, there is a four amino acid sequence (GlnThr-Ser-
Asp) that is shared between 37 and H-2Kd, -Kb, and -Kk cy-
toplasmic domains which could serve as a potential cross-
reactive determinant (1) . Thus, the anti-37 serum reacts
strongly with a protein of the same molecular weight and
pI as Qa-1.2 but fails to detect a molecule equivalent to Qa-1.1.
Several other Qa-1, (A/J, B10.BR, SWR, SJL) and Qa-1b
(B6, ATlab, BALB/c, DBA/2) strains were next examined
by immunoprecipitation with the Qa-1 and 37 antisera and
subjected to 1-D and 2-D analysis (Fig. 2, and data not shown) .
The results obtained with these additional strains are consis-
tent with the data already shown for B6 and B6Xla a . From
each of the Qa-1b strains, anti-37 immunoprecipitated a dou-
blet in the -48,000 mol wt range, the lower of which had
the same molecular weight as Qa-1.2 . Analysis on, 2-D gels
demonstrated that for each of these strains the anti-37 reac-
tive lower band was identical to Qa-1.2 ; as seen for B6, the
higher molecular weight species had a pI profile and charge
heterogeneity similar to the lower molecular weight species
(data not shown) . Examination of the Qa-1a strains revealed
that anti-37 did not react with the Qa-1.1 molecule . The
-48-50-kD species visible in the anti-37 lanes from B1O.BR
and SWR were not Qa-1.1 as determined by 2-D gels (not
shown) and again likely represent weak cross-reactivity with
other class I molecules . Thus, the 37 gene product is indis-
tinguishable in size, isoelectric point, and strain distribution
from Qa-1 from Qa-1b strains, but is not equivalent to or
detected in the different Qa-1a strains. studied .
Anti-Qa-1.2 andAnti-37 Sera Recognize theSame Class 1 Mol-
ecule by Immunodepletion Analysis. To determine if the mol-
ecule isolated by immunoprecipitation with anti-Qa-1.2 and
anti-37 were indeed the same, sequential immunoprecipita-
tion experiments were performed . Lysates from iodinatedB6
CAB were reacted with anti-37, NRS, anti-Qa-1.2, or NMS
in two preclearing cycles and aliquots of these precleared ly-
sates were then immunoprecipitated . As shown in Fig. 3,
depletion of the cell lysates with anti-37 efficiently removed
the 37 protein and all Qa-1.2 molecules as compared with
the NRS controls. H-2Kb molecules were unaffected by ei-
ther treatment . Lysate depletion with anti-Qa-1.2 removed
all Qa-1 molecules and effectively depleted the lower, but not
the uppermolwt species reactive with anti-37 serum . Thus,determinants recognized by anti-Qa-1.2 and anti-37 must reside
on the same molecule, confirming the 1-D and 2-D data in-
dicating Qa-1.2 and 37 to be the same .
The question still remained as to the identity ofthe higher
molecular weight species recognized by anti-37 but not anti-
Qa-1.2 in the Qa-1b strains . It is possible that the antiserum
crossreacts with an additional protein product distinct from
Figure 2.
￿
SDS-PAGE analysis ofQa-1
and the 37 gene product from different
Qa-12 and Qa-Ib mouse strains. Activated
T cell blasts from Qa-ib (ATlab, B6,
BALB/c, DBA/2) mice and Qa-12
(B10.BR, SJL, SWR, A/J) mice were io-
dinated and immunoprecipitated with
NRS, anti-37, anti-Qa-1.2 or -1 .1, and
NMS and analyzed by 1-D SDS-PAGE.
Qa-1.2 . A more reasonable explanation is that the highermo-
lecular weight species represents a modified glycosylated form
of Qa-1.2 which only the anti-37 peptide serum can detect .
It is not known what determinants on the Qa-1 molecule
the Qa-1.2 antiserum recognizes, but it has been documented
that carbohydrates can influence Qa-1 allodeterminants as de-
tected by CTL (31) . It is therefore possible that a modified
Figure 3 .
￿
Immunodepletion analysis ofQa-1 and the 37 gene product . B6 lysates were precleared with anti-37, NRS, anti-Qa-1 .2, or NMS . Samples
of lysates were then immunoprecipitated with anti-37, anti-Qa-1.2, anti-H-2K6 , or NMS and analyzed by 1-D SDS-PAGE.
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Qa-1.2 serum from recognizing this form of Qa-1.2. The
following experiments will address this question .
The 37 Antiserum Recognizes a Single Protein Product Iden-
tical to Qa-1. To investigate whether one or two protein prod-
ucts were recognized by the anti-37 serum, we used a short
term biosynthetic label followed by immunoprecipitation to
allow visualization of molecules that were minimally processed
(Fig. 4) . B6 CAB were internally labeled with [35S]methio-
nine for 30 min or labeled for 30 min and then chased for
1.5 and 4 h . The resulting lysates were immunoprecipitated
with anti-37, anti-Qa-1.2, anti-H-W, or NRS (not shown)
and analyzed by 2-D gels . The H-2Kb precipitated from the
internally labeled cellswas seen in predominantly unprocessed
form at 30 min (denoted by arrow) and processed form after
the chase. After the 30-min label, only a single co-migrating
protein species was detected by both the Qa-1.2 and 37 pep-
tide antisera (denoted by arrow), representing a glycosylated,
probably high mannose, immature form of Qa-1.2. Processing
of Qa-1.2 to its mature, complex sialylated form, could be
detected after a 1.5-h chase by both antisera . As seen in the
anti-37 serum panel, in addition to the species identical to
Qa-1.2, a higher molecular weight species emerged, presum-
ably the result of additional post-translational modifications
(denoted by arrowhead) . After a 4-h chase, only a small amount
could be detected with either antisera, indicating Qa-1 has
a more rapid turnover rate than H-2Kb which could still be
detected at 4 h (not shown; reference 11) . Consistent with
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the cell surface iodination experiments, the 37 antiserum was
unable to recognize a product from biosynthetically labeled
Qa-1 ° strains (data not shown) .
Contribution ofN-linked Carbohydrates to the Recognition of
Qa-I 6 by Anti-Qa-1.2 andAnti-37. Since the biosynthetic ex-
periments indicated thattwo different protein products were
probably not being recognized by anti-37,we next examined
whether the higher molecular weight species was the result
of a modified Winked glycosylation, that only the peptide
antiserum could detect . Anti-Qa-1.2 and anti-37 immuno-
precipitates fromB6 were digested with N-glycanase, an en-
zyme that hydrolyzes Winked oligosaccharides from glyco-
proteins . Fig . 5 A demonstrates that most of the higher
molecular weight species and the 48-kD molecules of both
precipitates were reduced to a single peptide of N38-kD by
digestion with N-glycanase ; this is the size predicted for the
nonglycosylated gene 37-encoded molecule and consistent
with the size determined previously for Qa-1.2 (28) . The fact
that both of the anti-37 reactive species were reduced to the
same molecular weight by deglycosylation again indicates that
the higher molecular weight species is not a protein different
from Qa-1.2 . Rather, it is the result of a post-translational
modification that blocks reactivity of the Qa-1.2 antiserum .
Fig . 5 B shows the2-D profiles of N-glycanase-treated anti-
37 and anti-Qa-1.2 precipitates . Both precipitates again showed
identical isoelectrophoretic patterns . When the digested anti-37
and anti-Qa-1.2 reactive molecules were mixed and analyzed
together, they completely comigrated, as seen on thebottom
Figure 4 . 2-D gel analysis of
metabolically labeled lysates from B6
Con A blasts . Cells were labeled
with 135S]methionine for 30 min
and or labeled for 30 min and then
chased for 1 .5 h . The lysates were
immunoprecipitated with anti-37,
anti-Qa-1.2, anti-H-W, or NRS
(not shown) . The high mannose
form of the isolated molecules is
denoted by a downward arrow.
Actin is denoted (a) . Equal areas for
each $uorogram are shown; the
basic end ofthe IEF first dimension
gel is to the left .Figure 5 .
￿
Analysis ofQa-1 .2 and the 37 gene product after removal of Winked carbohydrates. Iodinated B6 CAB lysates were immunoprecipitated
with anti-37, anti-Qa-1.2, orNRS (not shown), and then treated with 2U ofN-glycanase for 4 h. (A) SDS-PAGE analysis oftreated (+) and nontreated
(-) immunoprecipitates. The nonglycosylated form ofeach molecule is denotedby an arrow. (B) 2-D analysis of the N-glycanase treated and nontreated
immunoprecipitates. Equal areas ofeach autoradiogram are shown; the basic end of the IEF first dimension gel is to the left . The bottom panels show
the isoelectrophoretic patterns obtained after mixing equivalent portions of 37 and Qa-1.2 immunoprecipitates.
two panels of Fig. 5 B. Thus, the molecule reactive with
anti-37 and the Qa-1.2 molecule from Qa-Ib strains appear
to be identical.
As an alternative method to examining the contribution
of oligosaccharides to the higher molecular weight species
detected with anti-37 serum, we used the inhibitor of N-linked
glycosylation tunicamycin (32) . Tunicamycin inhibits the first
step in the processing of asparagine-linked oligosaccharides,
which involves the synthesis of dolichol N-acetylglucosamine
pyrophosphate (32, 33). The cell surfaceexpression ofQa-1,
unlike other class I molecules, can be dramatically inhibited
by tunicamycin . Cells cultured in the presence of low con-
centrations of tunicamycin (0.5 NAg/ml) for 8-12 h express
undetectable levels ofQa-1 as assessed by serologicaland bio-
chemical techniques (28) . Fig. 6 demonstrates the effect of
tunicamycin on the cell surface expression of Qa-1.2 . Cells
were incubatedwith or withouttunicamycin for 12 h, radio-
labeled with 'III, and then immunoprecipitated . In agree-
ment with previous data, cell surface Qa-1.2 was decreased
to a level undetectable by immunoprecipitation with either
37 or Qa-1.2 antiserum . Also, the higher molecular weight
species reactive with anti-37 serum was not detected . For
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H-W, both normal cell surface forms (molecules that did
not turnover or escaped the tunicamycin treatment) as well
as nonglycosylated forms were detected . Thus, tunicamycin,
which inhibits theaddition of N-linked oligosaccharides, com-
pletelyblocked the cell surface expression of Qa-1.2 and the
37 protein .
We next used biosynthetic labeling in the presence of
tunicamycin to examinewhether the same polypeptide in the
absenceofglycosylationwasrecognized by both anti-Qa-1.2
and anti-37 sera . Controland tunicamycin-treated cells were
labeled for 30 min with [35S]methionine, lysed, immunopre-
cipitated, and analyzed on 2-D gels (Fig. 7) . After a 30-min
labeling in thepresence of tunicamycin, much ofQa-1 present
was in the nonglycosylated form (up arrow), as opposed to
the "high mannose" form in nontreated cells (down arrow) .
As can be seen, the 2-D profiles of both the Qa-1.2 and 37
immunoprecipitates were identical for both the control and
tunicamycin treated samples .
These data further argue that the Qa-1.2 antigen from
Qa-ib strains is encoded by gene 37 . Like Qa-1, both mo-
lecular weight species reactive with anti-37 serum were ex-
quisitely sensitive to tunicamycin treatment andwere not ex-Figure 6 .
￿
Effect of tunicamycin on the cell surface expression of anti-
Qa-1 .2 and anti-37 reactive molecules . B6 Con A blasts were cultured in
the presence or absence of 0.5 hg/ml tunicamycin for 12 h and then cell
surface labeled with 1251 . Lysates were immunoprecipitated with anti-H-
2Kb, anti-Qa-1 .2, anti-37, and NRS and analyzed by 1-D SDS-PAGE .
pressed on the cell surface. Also, thepolypeptides synthesized
in the presence of tunicamycin were identical as shown by
the 2-D gels.
1801
￿
Wolf and Cook
Discussion
We have demonstrated that the product ofgene 37 is iden-
tical to the Qa-1 antigen of H-2Kb.dy °"d k(Qa-1 b) mouse
strains. Biochemical analysis ofmolecules reactive with Qa-1.2
antisera and antisera directed against a peptide deduced from
the 37 gene sequence revealed that these molecules have iden-
tical molecular weight, charge heterogeneity, and comigrate
with one another on 2-D gels . Sequential immunoprecipita-
tion experiments confirmed that the determinants recognized
by both antisera reside on the same class I molecule.
The anti-37 serum also detected a slightly higher Mr
product which did not react with anti-Qa-1.2 serum. Several
lines of evidence indicate that this species results from a mod-
ification ofWinked oligosaccharides on Qa-1 . Deglycosyla-
tion with N-glycanase reduced the molecular weight to that
seen for Qa-1.2 . Also, the biosynthesis experiments in the
presence and absence of tunicamycin revealed that the non-
glycosylated and the subsequent glycosylated forms of the
polypeptide detected by anti-Qa-1.2 and anti-37 sera were
the same ; the higher molecular weight species precipitated
by anti-37 serum was visualized only after a 1-1.5-h chase.
The inability of the anti-Qa-1.2 sera to react with the higher
molecular weight form is most likely due to a modification
of theWinked oligosaccharides that somehow alters folding
of the molecule or sterically blocks recognition of allodeter-
minants. The modified glycosylation would not be expected
to hinder binding by the anti-peptide serum because it is
directed against the cytoplasmic domain. The specific oligosac-
Figure 7 .
￿
Effect of tunicamycin
on the biosynthesis of Qa-1.2 and
the 37 gene product . B6 Con A
blasts were labeled with 135S]me-
thioninein the presence or absence
of tunicamycin (10 ug/ml) . The ly-
sates were immunoprecipitated with
Qa-1.2 and 37 antisera and analyzed
by 2-D gel electrophoresis . The high
mannose form of the isolated mol-
ecules is denoted by a downward
arrow. The nonglycosylated form of
the molecules is denoted by an up-
ward arrow. The a denotes actin .
Equal areas ofeach $uorogram are
shown; thebasic end ofthe IEF first
dimension gel is to the left .charide modification responsible for this higher Mr species
is not clear. The addition of sialic acids alone are not the cause
as demonstrated by neuraminidase digestion experiments (data
not shown) .
The Qa-1 product encoded by gene 37 is unusual among
class I antigens in its extreme dependenceon N-linked glycosy-
lation for cell surface expression. Also novel is the apparent
blocking of Qa-1 allodeterminants by oligosaccharides de-
scribed above. Data in this report using the anti-37 peptide
serum reiterate our previous findings usingtunicamycin (28)
and imply that Qa-1 stability, folding, peptide binding, as-
sociation with 02-microglobulin, and/or transport are dra-
matically influenced by N-linked glycosylation. However, some
Qa-1 molecules are exported to the cell surface during 12-18-h
treatment with tunicamycin as demonstrated by anti-Qa-1
CTL analyses (31); some CT1Tdefined determinants were found
to be tunicamycin sensitive whereas others were not (31).
Of particular interest is the lack ofreactivity of the anti-37
serum for the Qa-1.1 antigen from the Qa-1a strains. There
are two possible explanations for this finding. First, the Qa-1
molecule from these strains may be encoded by a gene that
is allelic to gene 37 but whose cytoplasmic domain has diverged
such that it is not detected by the anti-37 peptide serum.
Second, the Qa-1 antigens from Qa-1a and Qa-Ib strains may
not be the products of allelic genes. There are several lines
of evidence that support the latter possibility. A candidate
gene allelic to gene 37 has been recently partially character-
ized using PCR in the Qa-1' strain A/J (34). Based on the
541 by analyzed, this gene appears to be a hybrid or chimeric
gene with its 5' portion (exon II) closely related to gene 37
and 3' regions (exon IV, exon V, intron 4) identical to the
T10° gene in BALB/c. Gene 37 and TIOc demonstrate 95%
homology by nucleotide sequence, have identical cytoplasmic
domains, and appear to be the result of gene duplication. The
no,/37 hybrid gene is transcribed but like T10c is presum-
ably incapable of translation to a normal class I antigen due
to a termination codon in exon IV (34). By Southern blots
and RNAse protection experiments the TIO°/37 chimeric
gene is the only 37-related gene found in A strain mice (34).
It is possible that the TIO®/37 hybrid gene encodes Qa-1
only if the termination codon in exon IV is read through,
and the exon encoding the cytoplasmic domain has mutated
such that the protein can no longer be recognizedby the anti-
37 serum. Therefore, it seems unlikely that the Qa-1.1 an-
tigen in Qa-la mice is encoded by a gene allelic to gene 37.
Instead, it seems to be encoded by an undefined gene that
is pseudoallelic.
The possibility that Qa-1.1 and Qa-1.2 molecules are prod-
ucts of different genes is consistent with a previous report
from this laboratory regarding Qa-1 expression in Qa-ld
strains. Distinct Qa-1 antigens reactive with Qa-1.1 and Qa-1.2
sera could be immunoprecipitated from these strains (35);
Qa-ld cells also expressed both Qa-la and Qa-Ib CTIrdefined
determinants (15). Even though we do not yet know which
gene encodes Qa-1.1 in Qa-1 a strains, the data convincingly
argue that it is not a true allele of gene 37 which encodes
Qa-1.2.
At present, it is not known which gene from the H-2b
strains B6 or B10 is equivalent to gene 37 from BALB/c (25).
Based on Southern blots there are two genes in B10 that hy-
bridize to a 37-specific probe(25). One is the 37 gene equiva-
lent and the other is T11b, which is allelic to T10c; the Tlib
is present in the described B10 cosmid library (36), while
the gene 37 equivalent is not (25). A recent report has demon-
strated that the T11b is transcribed in lymphoid tissues and
in L cells transfected with the gene (37). A protein product
of -41 kD could be immunoprecipitated from the transfec-
tants with several mAbs that react with various H-2K/D as
well as Qa-2 molecules. However, a protein product could
not be detected on lymphoid cells by immunoprecipitation
or immunofluorescence, demonstrating that if a T11b-encoded
protein product is expressed in vivo it is at undetectable levels
(37). Efforts are underway to screen a new H-2b cosmid li-
brary to identify the gene allelic to BALB/c and DBA/2 gene
37 that encodes Qa-1.2.
With the elucidation of the gene that encodes a Qa-1 an-
tigen it should be more feasible (e.g., transgene and muta-
genesis studies) to explore the biological functions of the Qa-1
alloantigens, including their roles as classical peptide bind-
ing/presentation molecules, their restriction of .y/6 and/or
a//3 T cells, or possibly the description of novel functions.
Based on the HLAA2 crystal structure there are no features
that would be predicted to preclude the gene 37-encoded
Qa-1 from assuming a normal class I conformation complete
with a peptide binding cleft (21-23). The fact that the al
and a2 domains of gene 37 are quite divergent from most
other class I genes coupled with the low polymorphism imply
that the peptides bound may be distinct, or limited as com-
pared with those bound by conventional class I antigens. Such
functions, namely, the binding of mitochondrial N-formylated
peptides, have been ascribed to the maternally transmitted
antigen encoded telomeric to TL (38, 39) . Thus, the non-
classical class I antigens may have unusual peptide binding
properties and subserve specialized functions.
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